News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
811,551 Results
Type
Article (55439)
Company Profile (713)
Press Release (755372)
Multimedia
Podcasts (192)
Webinars (31)
Section
Business (226322)
Career Advice (3010)
Deals (38960)
Drug Delivery (164)
Drug Development (88038)
Employer Resources (191)
FDA (17927)
Job Trends (16819)
News (382742)
Policy (36918)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (2831)
Academic (2)
Accelerated approval (47)
Adcomms (35)
Allergies (184)
Alliances (55318)
ALS (222)
Alzheimer's disease (1897)
Antibody-drug conjugate (ADC) (480)
Approvals (18239)
Artificial intelligence (743)
Autoimmune disease (298)
Automation (57)
Bankruptcy (402)
Best Places to Work (12432)
BIOSECURE Act (23)
Biosimilars (233)
Biotechnology (445)
Bladder cancer (193)
Brain cancer (78)
Breast cancer (780)
Cancer (6054)
Cardiovascular disease (510)
Career advice (2565)
Career pathing (48)
CAR-T (345)
CDC (69)
Celiac Disease (3)
Cell therapy (957)
Cervical cancer (48)
Clinical research (75748)
Collaboration (2220)
Company closure (8)
Compensation (1416)
Complete response letters (99)
COVID-19 (2980)
CRISPR (118)
C-suite (1179)
Cystic fibrosis (160)
Data (7901)
Decentralized trials (3)
Denatured (65)
Depression (180)
Dermatology (85)
Diabetes (614)
Diagnostics (7418)
Digital health (58)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (357)
Drug pricing (237)
Drug shortages (38)
Duchenne muscular dystrophy (299)
Earnings (99505)
Editorial (76)
Employer branding (24)
Employer resources (167)
Events (133467)
Executive appointments (1154)
FDA (21734)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1819)
Gene editing (257)
Generative AI (73)
Gene therapy (791)
GLP-1 (1216)
Government (5222)
Grass and pollen (8)
Guidances (411)
Healthcare (20509)
HIV (84)
Huntington's disease (61)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (101)
Immunology and inflammation (337)
Immuno-oncology (99)
Indications (181)
Infectious disease (3339)
Inflammatory bowel disease (236)
Inflation Reduction Act (16)
Influenza (142)
Intellectual property (299)
Interviews (563)
IPO (17828)
IRA (58)
Job creations (4758)
Job search strategy (2095)
JPM (71)
Kidney cancer (21)
Labor market (103)
Layoffs (665)
Leadership (48)
Legal (9328)
Liver cancer (105)
Longevity (34)
Lung cancer (790)
Lymphoma (434)
Machine learning (62)
Management (65)
Manufacturing (1099)
MASH (200)
Medical device (15030)
Medtech (15146)
Mergers & acquisitions (22384)
Metabolic disorders (1638)
mRNA (234)
Multiple sclerosis (194)
NASH (22)
Neurodegenerative disease (456)
Neuropsychiatric disorders (118)
Neuroscience (3510)
Neurotech (1)
NextGen: Class of 2026 (7377)
Non-profit (4875)
Now hiring (78)
Obesity (792)
Opinion (359)
Ovarian cancer (223)
Pain (266)
Pancreatic cancer (308)
Parkinson's disease (379)
Partnered (37)
Patents (616)
Patient recruitment (694)
Peanut (67)
People (65724)
Pharmaceutical (127)
Pharmacy benefit managers (36)
Phase 1 (23560)
Phase 2 (33222)
Phase 3 (24904)
Pipeline (8529)
Policy (367)
Postmarket research (2899)
Preclinical (10159)
Press Release (71)
Prostate cancer (309)
Psychedelics (68)
Radiopharmaceuticals (348)
Rare diseases (1168)
Real estate (6936)
Recruiting (78)
Regulatory (28022)
Reports (63)
Research institute (2609)
Resumes & cover letters (472)
Rett syndrome (37)
RNA editing (24)
RSV (98)
Schizophrenia (190)
Series A (311)
Series B (224)
Service/supplier (28)
Sickle cell disease (120)
Special edition (30)
Spinal muscular atrophy (179)
Sponsored (52)
Startups (4212)
State (2)
Stomach cancer (21)
Supply chain (138)
Tariffs (104)
The Weekly (124)
Vaccines (1229)
Venture capital (121)
Weight loss (540)
Women's health (127)
Worklife (24)
Date
Today (205)
Last 7 days (1002)
Last 30 days (3457)
Last 365 days (32388)
2026 (12340)
2025 (32300)
2024 (37634)
2023 (42370)
2022 (53730)
2021 (58434)
2020 (57102)
2019 (50284)
2018 (38161)
2017 (35684)
2016 (35934)
2015 (41953)
2014 (36350)
2013 (31667)
2012 (33484)
2011 (33748)
2010 (32130)
Location
Africa (985)
Alabama (100)
Alaska (7)
Arizona (368)
Arkansas (16)
Asia (47239)
Australia (7881)
California (13560)
Canada (3796)
China (1421)
Colorado (586)
Connecticut (598)
Delaware (413)
Europe (106026)
Florida (2005)
Georgia (434)
Hawaii (4)
Idaho (66)
Illinois (1119)
India (96)
Indiana (630)
Iowa (25)
Japan (542)
Kansas (137)
Kentucky (54)
Louisiana (45)
Maine (88)
Maryland (1641)
Massachusetts (9906)
Michigan (397)
Minnesota (752)
Mississippi (6)
Missouri (158)
Montana (36)
Nebraska (30)
Nevada (147)
New Hampshire (92)
New Jersey (3610)
New Mexico (34)
New York (3555)
North Carolina (1828)
North Dakota (10)
Northern California (6700)
Ohio (418)
Oklahoma (26)
Oregon (53)
Pennsylvania (2698)
Puerto Rico (30)
Rhode Island (53)
South America (1398)
South Carolina (87)
South Dakota (2)
Southern California (5312)
Tennessee (212)
Texas (2171)
United States (48442)
Utah (409)
Vermont (1)
Virginia (345)
Washington D.C. (88)
Washington State (1116)
West Virginia (4)
Wisconsin (147)
Wyoming (2)
811,551 Results for "bain and company inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Startups
BMS, Bain Birth Biotech for Autoimmune Disorders
BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus erythematosus and plaque psoriasis, and $300 million in funds from Bain Capital.
July 29, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Bain Bets Big on Japanese Market With $3.3B Tanabe Buy
The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences market, recently revitalized by more industry-friendly policy changes from the government.
February 10, 2025
·
1 min read
·
Tristan Manalac
Funding
Bain Raises $3B for Fourth Fund to Back Promising Life Sciences Companies
Tuesday’s round brings Bain Capital Life Sciences’ fundraising total to around $6.7 billion since its founding in 2016. Many of its portfolio companies have resulted in high-value exits recently, including Cerevel Therapeutics, Aiolos Bio and Jnana Therapeutics.
September 11, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of Patients
July 29, 2025
·
6 min read
Press Releases
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
May 5, 2026
·
8 min read
Press Releases
Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital
January 28, 2025
·
2 min read
Press Releases
Io Therapeutics, Inc. announces publication of studies on the company’s RXR agonist compound IRX4204 for breast cancer prevention
March 11, 2026
·
3 min read
Press Releases
Remix Therapeutics Appoints Linda C. Bain to Board of Directors
April 16, 2025
·
2 min read
Press Releases
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company
April 2, 2026
·
4 min read
Press Releases
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
February 7, 2025
·
4 min read
1 of 81,156
Next
